SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells

Key Points SF3B1 mutations in MDS-RS have a multipotent lymphomyeloid origin. Transplantation of SF3B1 mutated MDS-RS HSCs into immune-deficient mice results in generation of characteristic ring sideroblasts.